Sacha Ghai

Senior Partner, McKinsey & Company

Sacha Ghai is a Director (Senior Partner) in the Toronto office of McKinsey & Company.


He leads McKinsey’s Global Institutional Investor service line, which includes pension plans, sovereign wealth funds, endowments and family offices from around the world. He serves clients in North America, Europe and the Middle-East.


He has extensive experience serving institutional investors across a wide range of issues and asset classes.


Specifically, he has experience helping them develop their long term multi-asset class strategies (including investment philosophy, business model, and direct vs. indirect investing) and supporting risk management processes.


He also helps these institutions organize to deliver on their chosen strategies by improving their supporting investment processes (including due diligence on direct investments, and external manager selection criteria), as well as by improving the efficiency and effectiveness of all middle and back office functions, including risk management and cost management.


He also focuses on helping large institutional investors improve their investment oversight and governance approaches and on aligning these approaches with their chosen strategies.


This has included developing innovative business models and structures in some cases (for example, setting up a captive vehicle to manage capital on behalf of third parties).


Sacha spent 1 year as a Fellow of the McKinsey Global Institute where he led a major research effort on the impact of global demographic change on international capital markets.


His work has been presented at the World Economic Forum in Davos, and appeared in various publications, including Business Week, the Financial Times, CBS News and McKinsey Quarterly. 


He is also a co-author of “The Best of Times and the Worst of Times for Institutional Investors”, a global perspective on long term investment strategies to help institutional investors navigate the next decade.


Sacha received a B.A.Sc. in Biochemistry from McMaster University and an MBA from the Harvard Business School.